mRNAワクチンの世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D06859)
◆英語タイトル:Global mRNA Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D06859
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年12月5日(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、mRNAワクチンの世界市場について調査・分析し、種類別には、がん治療用MRNAワクチンの標準化、個人用がん治療用MRNAワクチン、感染症治療用MRNAワクチン、感染予防MRNAワクチンに、用途別には、感染症、癌、その他に区分してまとめました。調査対象企業は、Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology等です。

・レポートの概要
・グローバル成長トレンド
・mRNAワクチンの世界市場規模
・mRNAワクチンの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別mRNAワクチンの価格動向
・mRNAワクチンの種類別市場規模(がん治療用MRNAワクチンの標準化、個人用がん治療用MRNAワクチン、感染症治療用MRNAワクチン、感染予防MRNAワクチン)
・mRNAワクチンの用途別市場規模(感染症、癌、その他)
・mRNAワクチンの北米市場(アメリカ、カナダ、メキシコ)
・mRNAワクチンのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・mRNAワクチンのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・mRNAワクチンの中南米市場(ブラジル等)
・mRNAワクチンの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・mRNAワクチンの市場規模予測
・mRNAワクチンの種類別市場予測2018-2025(がん治療用MRNAワクチンの標準化、個人用がん治療用MRNAワクチン、感染症治療用MRNAワクチン、感染予防MRNAワクチン)
・mRNAワクチンの用途別市場予測2018-2025(感染症、癌、その他)
・mRNAワクチンの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・mRNAワクチンのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・mRNAワクチンのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・mRNAワクチンの中南米市場予測2018-2025(ブラジル等)
・mRNAワクチンの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.In 2018, the global mRNA Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for mRNA Vaccine.

This study researches the market size of mRNA Vaccine, presents the global mRNA Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of mRNA Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of mRNA Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Market Segment by Product Type
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Market Segment by Application
Infectious Disease
Cancer
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global mRNA Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key mRNA Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of mRNA Vaccine are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global mRNA Vaccine Market Size Growth Rate by Type
1.3.2 Standardization Of Cancer Treatment MRNA Vaccine
1.3.3 Individualized Cancer Treatment MRNA Vaccine
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Market Segment by Application
1.4.1 Global mRNA Vaccine Market Share by Application (2018-2025)
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global mRNA Vaccine Market Size
2.1.1 Global mRNA Vaccine Revenue 2013-2025
2.1.2 Global mRNA Vaccine Sales 2013-2025
2.2 mRNA Vaccine Growth Rate by Regions
2.2.1 Global mRNA Vaccine Sales by Regions 2013-2018
2.2.2 Global mRNA Vaccine Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers 2013-2018
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2013-2018)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2013-2018)
3.2.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 mRNA Vaccine Price by Manufacturers
3.4 Key Manufacturers mRNA Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into mRNA Vaccine Market
3.6 Key Manufacturers mRNA Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Standardization Of Cancer Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.2 Individualized Cancer Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.3 Infectious Disease Treatment MRNA Vaccine Sales and Revenue (2013-2018)
4.1.4 Infection Prevention MRNA Vaccine Sales and Revenue (2013-2018)
4.2 Global mRNA Vaccine Sales Market Share by Type
4.3 Global mRNA Vaccine Revenue Market Share by Type
4.4 mRNA Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global mRNA Vaccine Sales by Application

6 North America
6.1 North America mRNA Vaccine Breakdown Data by Company
6.2 North America mRNA Vaccine Breakdown Data by Type
6.3 North America mRNA Vaccine Breakdown Data by Application
6.4 North America mRNA Vaccine Breakdown Data by Countries
6.4.1 North America mRNA Vaccine Sales by Countries
6.4.2 North America mRNA Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe mRNA Vaccine Breakdown Data by Company
7.2 Europe mRNA Vaccine Breakdown Data by Type
7.3 Europe mRNA Vaccine Breakdown Data by Application
7.4 Europe mRNA Vaccine Breakdown Data by Countries
7.4.1 Europe mRNA Vaccine Sales by Countries
7.4.2 Europe mRNA Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific mRNA Vaccine Breakdown Data by Company
8.2 Asia Pacific mRNA Vaccine Breakdown Data by Type
8.3 Asia Pacific mRNA Vaccine Breakdown Data by Application
8.4 Asia Pacific mRNA Vaccine Breakdown Data by Countries
8.4.1 Asia Pacific mRNA Vaccine Sales by Countries
8.4.2 Asia Pacific mRNA Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America mRNA Vaccine Breakdown Data by Company
9.2 Central & South America mRNA Vaccine Breakdown Data by Type
9.3 Central & South America mRNA Vaccine Breakdown Data by Application
9.4 Central & South America mRNA Vaccine Breakdown Data by Countries
9.4.1 Central & South America mRNA Vaccine Sales by Countries
9.4.2 Central & South America mRNA Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa mRNA Vaccine Breakdown Data by Type
10.2 Middle East and Africa mRNA Vaccine Breakdown Data by Application
10.3 Middle East and Africa mRNA Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa mRNA Vaccine Sales by Countries
10.3.2 Middle East and Africa mRNA Vaccine Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of mRNA Vaccine
11.1.4 mRNA Vaccine Product Introduction
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of mRNA Vaccine
11.2.4 mRNA Vaccine Product Introduction
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of mRNA Vaccine
11.3.4 mRNA Vaccine Product Introduction
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of mRNA Vaccine
11.4.4 mRNA Vaccine Product Introduction
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of mRNA Vaccine
11.5.4 mRNA Vaccine Product Introduction
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of mRNA Vaccine
11.6.4 mRNA Vaccine Product Introduction
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of mRNA Vaccine
11.7.4 mRNA Vaccine Product Introduction
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of mRNA Vaccine
11.8.4 mRNA Vaccine Product Introduction
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of mRNA Vaccine
11.9.4 mRNA Vaccine Product Introduction
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of mRNA Vaccine
11.10.4 mRNA Vaccine Product Introduction
11.10.5 Tiba Biotechnology Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 mRNA Vaccine Sales Channels
12.2.2 mRNA Vaccine Distributors
12.3 mRNA Vaccine Customers

13 Market Forecast
13.1 Global mRNA Vaccine Sales and Revenue Forecast 2018-2025
13.2 Global mRNA Vaccine Sales Forecast by Type
13.3 Global mRNA Vaccine Sales Forecast by Application
13.4 mRNA Vaccine Forecast by Regions
13.4.1 Global mRNA Vaccine Sales Forecast by Regions 2018-2025
13.4.2 Global mRNA Vaccine Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America mRNA Vaccine Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe mRNA Vaccine Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific mRNA Vaccine Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America mRNA Vaccine Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa mRNA Vaccine Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ mRNAワクチンの世界市場動向・分析2018-2025(Global mRNA Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。